Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population.
Qual Life Res 2015 Sep 28;24(9):2183-93. Epub 2015 Feb 28.
Institute of Health and Biomedical Innovation (IHBI), School of Nursing, Queensland University of Technology (QUT), Kelvin Grove, Brisbane, QLD, 4059, Australia,

A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.
BMC Cancer 2011 Apr 1;11:119. Epub 2011 Apr 1.
Australian Prostate Cancer Research centre-Queensland and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, Queensland 4059, Australia.

Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival.
Gynecol Oncol 2010 Dec 15;119(3):479-83. Epub 2010 Sep 15.
Molecular Cancer Epidemiology, Queensland Institute of Medical Research, P.O. Royal Brisbane Hospital, Herston, Brisbane, QLD 4029, Australia.

Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.
Int J Gynecol Cancer 2010 May;20(4):529-36
School of Life Sciences, Hormone-Dependent Cancer Research Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Queensland, Australia.

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
Nat Genet 2009 Oct 20;41(10):1116-21. Epub 2009 Sep 20.
The Institute of Cancer Research, Sutton, Surrey, UK.

PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
Carcinogenesis 2007 May 6;28(5):1032-9. Epub 2006 Dec 6.
Cluster for Molecular Biotechnology, School of Life Sciences and Science Research Centre, Queensland University of Technology, Victoria Park Road, Kelvin Grove, Brisbane, QLD 4059, Australia

Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma.
J Allergy Clin Immunol 2004 May;113(5):889-95
Co-operative Research Centre for Asthma and the Asthma and Allergy Research Institute (Inc), Sir Charles Gairdner Hospital, University of Western Australia, Perth, WA 6009, Australia.